Twitter Twitter Facebook Facebook Linked In Linked In Zone In Zone In Google Plus Zone In

Research Update

Modified mRNA: Getting to the Heart of Gene Therapy

Messenger RNA for clinical use is not a new concept. In 2000 Rammensee, Jung and colleagues accidentally discovered that direct injection of messenger RNA elicits an immune response. This discovery led to years of research utilizing mRNA for vaccine development. A variety of characteristics gives mRNA a natural advantage over traditional vaccines.

Recently, the use of mRNA as a therapeutic agent has been gaining momentum again, this time as a tool for gene replacement.

Read More


New Service
mRNA Therapeutic GMP Manufacturing

New Products
View our expanding catalog of Epigenetic Research Reagents.

Don't miss the Fluorescent Biomolecules Conference in La Jolla, CA, August 6-9.
Recent Blog Post

Venter’s Latest Venture: Increasing Human Longevity

  • The Quest to Make 100 the New 60
  • Aiming to Sequence 100,000 Human Genomes Per Year (Wow!)
  • Adding Genomes, Microbiomes, and Metabolomes to Health Records May Lead to Better Health and Longevity

Read More



Venter relaxing on his 95-foot sailboat/research vessel. Photo: Rick Friedman/Corbis,

Cellular RNA consists of four major nucleosides and about 100 minor nucleosides, which are generated post-transcriptionally by enzymatic modification of the four major bases, or in exceptional cases, by base replacement. These natural minor nucleotides perform a large number of functions, some of which are yet to be discovered. We are continually expanding our catalog of naturally occurring RNA analogs to aide in this research.

View List

If you don’t see the analog you need, just ask!

Previous Blog Post

Crowdfunding: Science & Startups Go Social
  • Websites Proliferate for “Reaching out to Engage” for Needed Dollars
  • Academics, Universities and Startups are Now Crowdfunding
  • Some Projects Attract Big Buck But Most Get Little

    Read More

© 2014 TriLink BioTechnologies, Inc. | All Rights Reserved